<DOC>
	<DOCNO>NCT01125605</DOCNO>
	<brief_summary>The purpose observational study give overview use PASCONAL NERVENTROPFEN 2-4 week treatment nervous disease , especially sleep disorder due nervousness .</brief_summary>
	<brief_title>PASCONAL NERVENTROPFEN Treatment Nervous Diseases</brief_title>
	<detailed_description>The purpose observational study give overview use PASCONAL NERVENTROPFEN 2-4 week treatment nervous disease , especially sleep disorder due nervousness . Efficacy tolerability drug assess . Special regard take administration management , dose regimen , effectiveness safety special patient group ( child 1-12 year age ) , relation treatment conformity Summary Product Characteristics ( SmPC ) .</detailed_description>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<criteria>Due design Observational Study inclusion exclusion criterion therapy name . The included patient group describe `` Cohort / Group '' . Observational Criteria ( =inclusion criterion documentation ) : Males females Children 112 year old Adults &gt; 12 year old suffer nervous disease , e.g . sleep disorder due nervousness . Exclusion criterion documentation : child young 1 year nervous disease , e.g . sleep disorder due nervousness . treatment PASCONAL NERVENTROPFEN</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>PASCONAL</keyword>
	<keyword>nervousness</keyword>
	<keyword>nervosity</keyword>
	<keyword>sleep disorder</keyword>
</DOC>